Home | Welcome to Contract Pharma   
Last Updated Tuesday, June 18 2013
Print

Promotions & Moves

Related Searches:

Filter by:

December 3, 2010
HemaQuest Pharmaceuticals, Inc. has added three executives to its management team.   Read More »
December 1, 2010
Wesley P. Wheeler, chief executive officer and president of Patheon has left the company.   Read More »
November 30, 2010
Chris Beaver, Ph.D. has been appointed director of Immunochemistry Services at PharmaNet Development Group.   Read More »
November 30, 2010
Kenneth C. Frazier, currently president of Merck, has been appointed chief executive officer and president of the company, as well as a member of the board, effective January 1, 2011.   Read More »
November 23, 2010
Francois (Frans) L. Dubois has been named to the newly created position of senior vice president of Quality at Hospira, Inc., effective Jan. 3, 2011.   Read More »
November 22, 2010
Edward Rowland has been appointed head of operational analytical services for Penn Pharma.   Read More »
November 16, 2010
Aardema to serve as Tox-CSO   Read More »
November 12, 2010
Steven H. Collis has been appointed president and chief operating officer of AmerisourceBergen Corp., effective immediately.   Read More »
November 11, 2010
Richard Walovitch, Ph.D. has been named president of WorldCare Clinical, LLC (WCC).   Read More »
November 10, 2010
Dr. Lawrence S. Olanoff, president and chief operating officer of Forest Laboratories, will retire effective December 31, 2010. Additionally, the company has made several executive management promotions.   Read More »
November 9, 2010
Dr. Manfred Weiler has been appointed vice president of Alliance Development for INC Research, Inc.   Read More »
November 8, 2010
Dr. David Pushett has been appointed director of global business development at Porsolt.   Read More »
November 8, 2010
Mills to step down as CEO, retain chairman role   Read More »
November 4, 2010
Jan Hendrik Egberts, M.D. has been appointed chief executive officer of   Read More »
November 2, 2010
Donald B. Rice, Ph.D. will retire from Agensys, Inc., an affiliate of Astellas Pharma, Inc.   Read More »
Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:

Follow Contract Pharma On